BRIEF published on 01/17/2025 at 22:33, 1 year 5 months ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 1 year 5 months ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 1 year 5 months ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
BRIEF published on 01/13/2025 at 13:05, 1 year 5 months ago Moderna présente ses orientations stratégiques lors de la conférence JP Morgan Healthcare Approbations De Vaccins Finances Moderna Prévisions De Revenus Pour 2025 Plan De Réduction Des Coûts Étapes Clés Du Pipeline
PRESS RELEASE published on 01/13/2025 at 13:00, 1 year 5 months ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year 6 months ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF published on 11/25/2024 at 13:05, 1 year 6 months ago Moderna présentera ses résultats financiers lors des conférences d'investisseurs de décembre 2024 Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
PRESS RELEASE published on 11/25/2024 at 13:00, 1 year 6 months ago Moderna to Present at Upcoming Conferences in December 2024 Moderna, Inc. announces participation in investor conferences and highlights mRNA technology advancements. Company overview and contact info provided Investor Conferences Healthcare MRNA Technology Moderna Vaccines
BRIEF published on 11/12/2024 at 14:20, 1 year 7 months ago Moderna Tops BioSpace's Best Places to Work for Fourth Year Innovation AI Integration Life Sciences Moderna Workplace Ranking
BRIEF published on 11/12/2024 at 14:20, 1 year 7 months ago Moderna est en tête du classement des meilleurs lieux de travail de BioSpace pour la quatrième année consécutive Innovation Intégration De L'IA Moderne Sciences De La Vie Classement Des Lieux De Travail
Published on 06/20/2026 at 01:00, 1 day 13 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 14 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 9 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 12 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 13 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 16 hours 46 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 8 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 17 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 17 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 19 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 18 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 18 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 18 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 18 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
